← FDA DRUG APPROVALS

FDA ANDA · ANDA202679

SODIUM BICARBONATE

Sponsor: HOSPIRA

APPLICATION
ANDA202679
TYPE
ANDA
ORIGINAL APPROVAL
2017-03-07
LATEST ACTION
2021-06-14
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

SODIUM BICARBONATEPrescription
SODIUM BICARBONATE 5MEQ/10ML (0.5MEQ/ML) · SOLUTION · INTRAVENOUS

Approval history

2021-06-14Manufacturing (CMC) · Supplement 10 · unknownAP
2017-08-29Labeling · Supplement 2 · standardAP
2017-03-07UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →